Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma.

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

1995 • 1,320 citations

Natural history and therapy of metastatic renal cell carcinoma

1997 • 324 citations

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma

2002 • 166 citations

Therapeutic options in the management of renal cell carcinoma

2002 • 89 citations